Charles Faith L. 4

What Happened
Charles Faith, a director of CNS Pharmaceuticals, reported a purchase of 7,100 shares on May 18, 2026. The Form 4 lists the transaction as a purchase (code P) at $4.79 per share, for a total cost of approximately $34,002. This was an acquisition (purchase), which is generally considered more informative than a sale because it involves the insider deploying personal capital.

Key Details

• Transaction date: 2026-05-18; filing date: 2026-05-20 (filed within the standard two-business-day reporting window).
• Price and quantity: 7,100 shares at $4.79 per share; total ≈ $34,002.
• Shares owned after transaction: Not specified in the provided filing.
• Transaction code: P (purchase — open market or private purchase per the Form 4).
• Filing notes: Includes Exhibit 24 (Power of Attorney).

Context
This is a straightforward equity purchase by a company director. The dollar amount is modest relative to many insider trades; it reflects a personal buy rather than an option exercise, gift, or tax-withholding event. The filing appears timely and contains a power-of-attorney exhibit, which may indicate an authorized filer signed on the insider’s behalf.